Program
Invited Speakers
-
D. Bennett: Surrogate Markers for Resistance Testing in Resource-Poor Settings
Diane E. Bennett, MD MPH, is the Senior Epidemiologist in the HIV Drug Resistance Team in the HIV Department at the World Health Organization (WHO). She received her medical degree from the University of Massachusetts, and did post-graduate training at Georgetown University Medical Centers, Johns Hopkins Medical Center, ...
Read more
-
R. Camacho: Genetic barriers: wise use of new drugs
Ricardo Camacho graduated in Medicine in Lisbon Medical School, Universidade de Lisboa. With a specialization in Transfusion Medicine, and several years of clinical practice, he becomes in 1994 the head of Virology Laboratory in Hospital Egas Moniz, in Lisbon, later one of the Portuguese AIDS reference laboratories.
...
Read more
-
S. Deeks: Integrase Resistance and Its Clinical Implications
Steven G. Deeks, MD is an Associate Clinical Professor of Medicine at the University of California, San Francisco. He received his medical degree from the University of California, San Francisco, and did post-graduate training in internal medicine at this institution. After joining the faculty in 1993, his research focused on the clinical development of novel anti-HIV therapies. In 1997, his interests turned to evaluating the immunologic ...
Read more
-
C. Federico Perno: Resistance in Resource-Limited Settings
Professor Carlo-Federico Perno is Professor of Virology at the University of Rome ‘Tor Vergata’, Italy, and Director of the Unit of Molecular Virology at the Tor Vergata University Hospital, Rome, Italy. He also works as consultant of Clinical Virology at the Spallanzani Hospital for Infectious Diseases. Professor Perno gained his MD from the University of Rome in 1980, and ...
Read more
-
P. Nyren: The history of Pyrosequencing – a second-generation DNA sequencing technology
Paul Nyren, Professor in Biochemistry at the School of Biotechnology Albanova University center, The Royal Institute of Technology. Scientific background in different fields such as bioenergetics, biomembranes, bioluminescence, molecular biology and cell biology. Current fields of interest includes the field of applied
...
Read more
-
J. Schapiro: Prioritizing Resistance in Future Antiretroviral Therapy
Jonathan M. Schapiro MD, is Clinical Assistant Professor at Stanford University School of Medicine, Stanford, California, and Director of the AIDS Service, National Hemophilia Center, at Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Israel. Dr Schapiro received his medical degree from Ben Gurion University of the Negev Medical School Israel, ...
Read more
-
B. Shafer: New Diagnostic Technologies (454 sequencing and other new technologies)
Dr. Bob Shafer is an Assistant Professor of Medicine at Stanford University and is the Medical Director of the HIV Antiretroviral Drug Testing Program at Stanford University Hospital. His research is on the mechanisms and consequences of HIV evolution with an emphasis on HIV drug resistance ...
Read more
-
A. Wensing: Transmission of HIV-Drug Resistance: A European Perspective
Dr. Anne Wensing, MD, PhD is a Clinical Virologist at the University Medical Center Utrecht. She has worked for several years at the outpatient clinic of the department of infectious diseases and AIDS, before her training as a clinical virologist. She is the clinical supervisor of the HIV resistance unit at the department of virology which serves as a ...
Read more
-
M. Zazzi: The Power and Limitations of Large Database Analyses
Maurizio Zazzi MSc, is Professor of Microbiology at the University of Siena, Italy. Dr. Zazzi graduated in Biological Sciences and later obtained a Master's degree in Microbiology and Virology at the University of Siena, Italy. At the Department of Molecular Biology of the same university he has continuously worked on the development ...
Read more
